Communications
Wengel, Chem. Commun. 1998, 455; e) L. Zhang, A. Peritz, E.
Meggers, J. Am. Chem. Soc. 2005, 127, 4174.
[20] a) R. A. Sanchez, L. E. Orgel, J. Mol. Biol. 1970, 47, 531;
b) W. D. Fuller, R. A. Sanchez, L. E. Orgel, J. Mol. Evol. 1972, 1,
249; c) G. Zubay, T. Mui, Origins Life Evol. Biosphere 2001, 31,
87.
[8] a) N. K. Sharma, K. N. Ganesh, Chem. Commun. 2003, 2484;
b) T. H. S. Tan, D. T. Hickman, J. Morral, I. G. Beadham, J.
Mickelfield, Chem. Commun. 2004, 516; c) P. von Matt, A.
De Messmaker, U. Pieles, W. Zürcher, K.-H. Altmann, Tetrahe-
dron Lett. 1999, 40, 2899; d) T. Vilaivan, G. Lowe, J. Am. Chem.
Soc. 2002, 124, 9326; e) R. A. Goodnow, S. Tam, D. L. Pruess, W.
McComas, Tetrahedron Lett. 1997, 38, 3199.
[9] a) M. Kuwahara, M. Arimitsu, M. Shigeuasu, N. Saeki, M. Sisido,
J. Am. Chem. Soc. 2001, 123, 4653; b) A. Lenzi, G. Reginato, M.
Taddei, E. Trifilieff, Tetrahedron Lett. 1995, 36, 1717; c) U.
Diederichsen, Angew. Chem. Int. Ed. Engl. 1996, 35, 445;
d) A. M. Brückner, H. W. Schmitt, U. Diederichsen, Helv. Chim.
Acta 2002, 85, 3855; e) M. Fuji, K. Yoshida, J. Hidaka, T. Ohtsu,
Chem. Commun. 1998, 717; f) Y. Huang, S. Dey, X. Zhang, F.
Sönnichsen, P. Garner, J. Am. Chem. Soc. 2004, 126, 4626; g) H.
Umemiya, K. Komatsu, T. Yamzaki, H. Kagechika, K. Shudo, Y.
Hashimoto, Nucleic Acids Symp. Ser. 1995, 34, 37.
[21] a) C. G. Overberger, F. W. Michelotti, P. M. Carabateas, J. Am.
Chem. Soc. 1957, 79, 941; b) H. Bredereck, F. Effenberger, A.
Hoffmann, M. Hajek, Angew. Chem. 1963, 75, 825; Angew.
Chem. Int. Ed. Engl. 1963, 2, 655; c) E. Kuwano, E. Taniguchi, K.
Maekawa, Agric. Biol. Chem. 1973, 37,423; d) J. K. Simons,
M. R. Saxton, Org. Synth. Collect. Vol. IV, Wiley, New York,
1963, pp. 78; e) E. M. Smolin, L. Rapoport, The Chemistry of
Heterocyclic Compounds, Vol. 13 (Ed.: A. Weissberg), Wiley,
New York, 1959; f) J. T. Thurston, US 2,460,397, Jan. 18, 1949.
[22] The reaction of biguanide with a-amino acid esters to afford 6-
alkylamino-substituted 2,4-diamino-1,3,5-triazines has been
mentioned in a patent by Thurston.[21f] Kuwano et al.[21c] have
described the preparation
a variety of 2,4-diaminotriazine
derivatives by the reaction of morpholinobiguanide and dime-
thylbiguanide with a-amino acid esters.
[23] a) T. K. Park, J. Schroeder, J. Rebek Jr., J. Am. Chem. Soc. 1991,
113, 5125; b) T. K. Park, J. Rebek Jr., J. Am. Chem. Soc. 1992,
114, 4529; c) G. M. Whitesides, E. R. Simanek, J. P. Mathias,
C. T. Seto, D. N. Chin, M. M. Mammen, D. M. Gordon, Acc.
Chem. Res. 1995, 28, 37; d) K. Kurihara, K. Ohto, Y. Honda, T.
Kunitake, J. Am. Chem. Soc. 1991, 113, 681; e) K. Ariga, T.
Kunitake, Acc. Chem. Res. 1998, 31, 371; f) H. Asanuma, T. Ban,
S. Gotoh, T. Hishiya, M. Komiyama, Macromolecules 1998, 31,
371; g) T. Kawasaki, M. Tokuhiro, N, Kimizuka, T. Kunitake, J.
Am. Chem. Soc. 2001, 123, 6792; h) O. Slinchenko, A. Rachkov,
H. Miyachi, M. Ogiso, N. Minoura, Biosens. Bioelectron. 2004,
20, 1091.
[10] H. Wippo, F. Reck, R. Kudick, M. Ramaseshan, M. Bolli, G.
Ceulemans, R. Krishnamurthy, A. Eschenmoser, Bioorg. Med.
Chem. 2001, 9, 2411.
[11] Generational refers to generating a given molecule.
[12] a) S. L. Miller, L. E. Orgel, The Origins of Life on the Earth,
Prentice-Hall, Englewood Cliffs, NJ, 1974; b) L. E. Orgel, Crit.
Rev. Biochem. Mol. Biol. 2004, 39, 99.
[13] What is to be meant as prebiotically realistic is and necessarily
remains a matter of continuing debate, one that, however, can
progressively be subjected to experimental scrutiny, for example,
see: K. Nelson, M. Levy, S. L. Miller, Proc. Natl. Acad. Sci. 2000,
97, 3868.
[24] a) P. Pithova, A. Piskala, J. Pitha, F. Sorm, Collect. Czech. Chem.
Commun. 1965, 30, 90; b) M. Winkley, R. K. Robins, J. Org.
Chem. 1970, 35, 491; c) H. Dugas, B. J. Blackburn, R. K. Robins,
R. Deslauriers, I. C. P. Smith, J. Am. Chem. Soc. 1971, 93, 3468;
d) T. A. Riley, W. J. Hennen, N. K. Dalley, B. E. Wilson, R. K.
Robins, J. Heterocycl. Chem. 1986, 23, 1709; e) D. Gasparutto, S.
Da Cruz, A.-G. Boudat, M. Jaquinod, J. Cadet, Chem. Res.
Toxicol. 1999, 12, 630; f) R. G. Garcia, A. S. Brank, J. K.
Christman, V. E. Marquez, R. Erija, Antisense Nucleic Acid
Drug Dev. 2001, 11, 369; g) J. A. Beisler, J. Med. Chem. 1978, 21,
204; h) M. Hysell, J. S. Siegel, Y. Tor, Org. Biomol. Chem. 2005,
3, 2946.
[25] B. Han, B. Jaun, R. Krishnamurthy, A. Eschenmoser, Org. Lett.
2004, 6, 3691.
[26] P. E. Nielsen, M. Egholm, R. H. Berg, O. Buchardt, Science 1991,
254, 1497.
[27] H. Moser, A. Fliri, A. Steiger, G. Costello, J. Schreiber, A.
Eschenmoser, Helv. Chim. Acta 1986, 69, 1224.
[28] To include in our study peptoid oligomers as achiral variants of
the di-aspartate derived oligomers of type B has been proposed
by F.D.R. (A.E.).
[14] a) M. Bolli, R. Micura, A. Eschenmoser, Chem. Biol. 1997, 4,
309; b) A. Saghatelian, Y. Yokobayashi, K. Soltani, M. R.
Ghadiri, Nature 2001, 409, 797; c) I. A. Kozlov, L. E. Orgel,
P. E. Nielsen, Angew. Chem. Int. Ed. 2000, 112, 4462; Angew.
Chem. Int. Ed. 2000, 39, 4292.
[15] See also, however, the opposite viewpoint in reference [16].
[16] a) W. A Bonner, Origins Life Evol. Biosphere 1992, 21, 407; b) S.
Pizarello, A. Weber, Science 2004, 303, 1151.
[17] a) N. J. Leonard, R. A. Laursen, J. Am. Chem. Soc. 1963, 85,
2026; b) N. J. Leonard, A. G. Morrice, M. A. Sprecker, J. Org.
Chem. 1975, 40, 356; c) A. G. Morrice, M. A. Sprecker, N. J.
Leonard, J. Org. Chem. 1975, 40, 363; d) J. A. Piccirilli, T.
Krauch, S. E. Moroney, S. E. Benner, Nature 1990, 343, 33;
e) S. A. Benner, Acc. Chem. Res. 2004, 37, 784; f) F. Seela, H.
Debelak, J. Org. Chem. 2001, 66, 3303; g) J. He, F. Seela, Helv.
Chim. Acta 2002, 85, 1340; h) F. Seela, R. Kröschel, Org. Biomol.
Chem. 2003, 1, 3900; i) B. A. Schweitzer, E. T. Kool, J. Am.
Chem. Soc. 1995, 117, 1863; j) E. T. Kool, Acc. Chem. Res. 2002,
35, 936; k) D. L. McMinn, A. K. Ogawa, Y. Wu, J. Liu, P. G.
Schultz, F. E. Romesberg, J. Am. Chem. Soc. 1999, 121, 11585;
l) A. H. Henry, F. E. Romesberg, Curr. Opin. Chem. Biol. 2003,
7, 727; m) I. Luyten, P. Herdewijn, Eur. J. Med. Chem. 1998, 33,
515.
[18] Systematic contributions to nucleobase variation have been
made by Leonard,[17a–c] Benner,[17d,e] Seela,[17f–h] Kool[17i,j] and
Romesberg[17k,l]. The criteria for choosing nucleobase variants in
these studies were different from those used in the present
project.
[19] a) J. Oro, A. Kimball, Biochem. Biophys. Res. Commun. 1960, 2,
407; b) J. P. Ferris, L. E. Orgel, J. Am. Chem. Soc. 1966, 88, 1074;
c) J. P. Ferris, R. A. Sanchez, L. E. Orgel, J. Mol. Biol. 1968, 33,
693; d) A. B. Voet, A. W. Schwartz, Bioorg. Chem. 1983, 12, 8;
e) M. P. Robertson, S. L. Miller, Nature 1995, 375, 772; f) S.
Miyakawa, H. J. Cleaves, S. L. Miller, Origins Life Evol.
Biosphere 2002, 32, 209.
[29] S. N. Holter, W. C. Fernelius, Inorg. Synth. 1963, 7, 58.
[30] a) Y. Watanabe, H. Usui, S. Kobayashi, H. Yoshiwara, T.
Shibano, T. Tanaka, Y. Morishima, M. Yasuoka, M. Kanao, J.
Med. Chem. 1992, 35, 189; b) H. Usui, Y. Watanabe, M. Kanao, J.
Heterocycl. Chem. 1993, 30, 551.
[31] All compounds were characterized by 1H and 13C NMR spec-
troscopy and mass spectrometry after purification by column
chromatography on silica gel. Oligodipeptides and oligodipep-
toids were synthesized on an Expedite 8909 Nucleic Acid
Synthesizer (Perseptive Biosystems) using a modified PNA-
protocol, purified by HPLC (ion exchange) to a minimal purity
of 95%% and checked by MALDI-TOF-MS (see Supporting
Information).
[32] It should be noted, however, that oligomer D(TN,N)12 differs
from the others carrying a positive charge in its backbone. We
ꢀ 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2007, 46, 2470 –2477